Leveraging the Expertise of the CTSA Program to Increase the Impact and Efficiency of Clinical Trials
Translational Research
Translational Science
DOI:
10.1001/jamanetworkopen.2023.36470
Publication Date:
2023-10-05T15:32:16Z
AUTHORS (105)
ABSTRACT
Multicenter clinical trials play a critical role in the translational processes that enable new treatments to reach all people and improve public health. However, conducting multicenter randomized (mRCT) presents challenges. The Trial Innovation Network (TIN), established 2016 partner with Clinical Translational Science Award (CTSA) Consortium of academic medical institutions implementation mRCTs, consists 3 Centers (TICs) 1 Recruitment Center (RIC). This unique partnership has aimed address roadblocks impede design conduct expectation accelerating translation novel interventions practice. TIN's challenges achievements are described this article, along examples innovative resources may serve as useful models for other trial networks providing operational recruitment support.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (37)
CITATIONS (10)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....